Importation Should Be Preemptive Tool During Shortages, Group Tells FDA

Importation of unapproved drugs should not remain the last resort for FDA when it is fighting a drug shortage, a hospital trade group told agency officials.

The weapon should be a more preemptive tool, Greater New York Hospital Association Ventures said during a meeting with Commissioner